Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digital PCR validation during planned imatinib discontinuation in chronic myeloid leukemia
2011-002749-37Phase 4Completed
- Sponsor
- University of Milano-Bicocca
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of imatinib in chronic myelogenous leukemia (CML), sponsored by University of Milano-Bicocca. Primary endpoint: Negative predictive value ratio of digital PCR over quantitative RT-PCR. Started Dec 2011; status: completed.
02
Drugs
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on 2011-002749-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002749-37.